Step into iCONFiT and all your worries as a fitness noob will go right out the window. There is no pre-conceived notion that an unfit Continue Reading
admin
Editorial administrator
Origin Agritech Further Strengthens its Board of Directors
BEIJING, July 30, 2018 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (“the Company” or “Origin”) an agricultural biotechnology trait and corn seed provider, today announced that Mr. Rong Continue Reading
WuXi Biologics Commenced Process Validation in MFG2
Produced 7 batches at 6,000L/12,000L bioreactor scale for three programs, the largest scale cell culture operations in China at 100% success rate in MFG2, the Continue Reading
Direct Relief Launches Facebook Fundraiser for Rohingya Mothers and Children
SANTA BARBARA, California, July 26, 2018 /PRNewswire/ — Direct Relief today launched a Facebook fundraiser to provide medical care to Rohingya mothers and children in the Continue Reading
CStone’s MEK Inhibitor CS3006 Receives IND Approval in China
SUZHOU, China, July 30, 2018 /PRNewswire/ — CStone Pharmaceuticals (CStone) today announced that its IND application for CS3006, a small-molecule inhibitor of mitogen-activated protein kinase Continue Reading
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-045, a Potent ALDH2 Activator
TAIPEI, Taiwan, July 26, 2018 /PRNewswire/ — Foresee Pharmaceuticals Co., Ltd. (6576.TWO) (“Foresee”), announced today that it has successfully completed a Phase 1 multiple ascending Continue Reading
Kimchi, a well-known traditional fermented Korean food, has proven effective against influenza virus
– Lactic acid bacteria, green onion and ginger in kimchi serve as natural antiviral agents, highly effective in preventing influenza. – Kimchi has the greatest Continue Reading
I-Mab Biopharma and ABL Bio Announce Global Collaboration on Innovative Bispecific Antibodies
SHANGHAI, July 26, 2018 /PRNewswire/ — I-Mab Biopharma (“I-Mab”), a company focusing on innovative biologics in immuno-oncology and immuno-inflammation, and ABL Bio Corporation (“ABL Bio”), Continue Reading
China Biologic Products to Report Second Quarter 2018 Financial Results
BEIJING, July 27, 2018 /PRNewswire/ — China Biologic Products Holdings, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in Continue Reading